The intestinal barrier in irritable bowel syndrome: Subtype-specific effects of the systemic compartment in an In Vitro model

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Ludidi, Samefko ^a   Jonkers, Daisy ^a   Elamin, Elhaseen ^a   Pieters, Harm Jan ^a   Schaepkens, Esther ^a   Bours, Paul ^a   Kruimel, Joanna ^a   Conchillo, José ^a   Masclee, Ad ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; LIPOPOLYSACCHARIDE; TRYPTASE;

ARTICLE; CACO 2 CELL LINE; CELL VIABILITY; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; EXPOSURE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINAL BARRIER; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; MALE; PERMEABILITY BARRIER; PLASMA; CACO-2 CELL LINE; DRUG EFFECTS; EXTRACELLULAR MATRIX; INTESTINE; METABOLISM;

CACO-2 CELLS; EXTRACELLULAR MATRIX; HUMANS; INTESTINES; IRRITABLE BOWEL SYNDROME; LIPOPOLYSACCHARIDES; TRYPTASES;

EID: 84929346679     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123498     Document Type: Article

References (45)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006 Apr; 130 (5) : 1480-91. PMID: 16678561
2. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002 Dec; 123 (6) : 2108-31. PMID: 12454866
3. Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, et al. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil. 2007 Jan; 19 (1 Suppl) : 62-88. PMID: 17280586
4. Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009 Feb; 104 (2) : 392-400. doi: 10.1038/ajg.2008.94 PMID: 19174797
5. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004 Mar; 126 (3) : 693-702. PMID: 14988823
6. Ringel Y, Maharshak N. The intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2013 Oct 15; 305 (8) : G529-41. doi: 10.1152/ajpgi.00207.2012 PMID: 23886861
7. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002 Jun; 122 (7) : 1778-83. PMID: 12055584
8. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology. 1995 Jul; 109 (1) : 40-52. PMID: 7797041
9. Camilleri M, Lasch K, Zhou W. The Confluence of Increased Permeability, Inflammation, and Pain in Irritable Bowel Syndrome. Am J Physiol Gastrointest Liver Physiol. 2012 Jul 26.
10. Barbara G. Mucosal barrier defects in irritable bowel syndrome. Who left the door open? Am J Gastroenterol. 2006 Jun; 101 (6) : 1295-8. PMID: 16771952
11. Bertiaux-Vandaele N, Youmba SB, Belmonte L, Lecleire S, Antonietti M, Gourcerol G, et al. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Am J Gastroenterol. 2011 Dec; 106-(12) : 2165-73. doi: 10.1038/ajg.2011.257 PMID: 22008894
12. Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006 Jun; 101 (6) : 1288-94. PMID: 16771951
13. Zhou Q, Zhang B, Verne GN. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain. 2009 Nov; 146 (1-2) : 41-6. doi: 10.1016/j.pain.2009.08.002 PMID: 19767149
14. Marshall JK, Thabane M, Garg AX, Clark W, Meddings J, Collins SM. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther. 2004 Dec; 20 (11-12) : 1317-22.
15. Ossovskaya VS, Bunnett NW. Protease-Activated receptors: contribution to physiology and disease. Physiol Rev. 2004 Apr; 84 (2) : 579-621. PMID: 15044683
16. Annahazi A, Ferrier L, Bezirard V, Leveque M, Eutamene H, Ait-Belgnaoui A, et al. Luminal Cysteine-Proteases Degrade Colonic Tight Junction Structure and Are Responsible for Abdominal Pain in Constipation-Predominant IBS. Am J Gastroenterol. 2013 Aug; 108 (8) : 1322-31. doi: 10.1038/ajg. 2013.152 PMID: 23711626
17. Gecse K, Roka R, Ferrier L, Leveque M, Eutamene H, Cartier C, et al. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut. 2008 May; 57 (5) : 591-9. doi: 10.1136/gut.2007.140210 PMID: 18194983
18. Roka R, Rosztoczy A, Leveque M, Izbeki F, Nagy F, Molnar T, et al. A pilot study of fecal serineprotease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2007 May; 5 (5) : 550-5. PMID: 17336590
19. Lee JW, Park JH, Park DI, Park JH, Kim HJ, Cho YK, et al. Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase. Dig Dis Sci. 2010 Oct; 55 (10) : 2922-8. doi: 10.1007/s10620-009-1094-8 PMID: 20087660
20. Benoit R, Rowe S, Watkins SC, Boyle P, Garrett M, Alber S, et al. Pure endotoxin does not pass across the intestinal epithelium in vitro. Shock. 1998 Jul; 10 (1) : 43-8. PMID: 9688090
21. Ge Y, Ezzell RM, Warren HS. Localization of endotoxin in the rat intestinal epithelium. J Infect Dis. 2000 Sep; 182 (3) : 873-81. PMID: 10950783
22. Elamin E, Jonkers D, Juuti-Uusitalo K, van Ijzendoorn S, Troost F, Duimel H, et al. Effects of ethanol and acetaldehyde on tight junction integrity: in vitro study in a three dimensional intestinal epithelial cell culture model. PLoS One. 2012; 7 (4) : e35008. doi: 10.1371/journal.pone.0035008 PMID: 22563376
23. Elamin E, Masclee A, Juuti-Uusitalo K, van Ijzendoorn S, Troost F, Pieters HJ, et al. Fatty acid ethyl esters induce intestinal epithelial barrier dysfunction via a reactive oxygen species-dependent mechanism in a three-dimensional cell culture model. PLoS One. 2013; 8 (3) : e58561. doi: 10.1371/journal. pone.0058561 PMID: 23526996
24. Collins TJ. ImageJ for microscopy. Biotechniques. 2007 Jul; 43 (1 Suppl) : 25-30. PMID: 17936939
25. Cuellar A, Fonseca A, Gomez A. Effect of lipopolysaccharides on human dendritic cell cultures and its inhibition by polymyxin B. Biomedica. 2004 Dec; 24 (4) : 413-22. PMID: 15678805
26. Zhou Q, Souba WW, Croce CM, Verne GN. MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut. 2010 Jun; 59 (6) : 775-84. doi: 10.1136/gut.2009.181834 PMID: 19951903
27. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000 Dec; 47 (6) : 804-11. PMID: 11076879
28. Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, et al. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther. 2012 Dec; 36 (11-12) : 1009-31. doi: 10.1111/apt.12053 PMID: 22994460
29. Lee H, Park JH, Park DI, Kim HJ, Cho YK, Sohn CI, Jet al. Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome. J Neurogastroenterol Motil. 2013 Apr; 19 (2) : 244-50. doi: 10.5056/jnm.2013.19.2.244 PMID: 23667756
30. Amadesi S, Nie J, Vergnolle N, Cottrell GS, Grady EF, Trevisani M, et al. Protease-Activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci. 2004 May 5; 24 (18) : 4300-12. PMID: 15128844
31. Bohm SK, Kong W, Bromme D, Smeekens SP, Anderson DC, Connolly A, et al. Molecular cloning, expression and potential functions of the human proteinase-Activated receptor-2. Biochem J. 1996 Mar 15; 314 (Pt 3) : 1009-16. PMID: 8615752
32. Maltman DJ, Przyborski SA. Developments in three-dimensional cell culture technology aimed at improving the accuracy of in vitro analyses. Biochem Soc Trans. 2010 Aug; 38 (4) : 1072-5. doi: 10.1042/BST0381072 PMID: 20659006
33. Juuti-Uusitalo K, Klunder LJ, Sjollema KA, Mackovicova K, Ohgaki R, Hoekstra D, et al. Differential effects of TNF (TNFSF2) and IFN-gamma on intestinal epithelial cell morphogenesis and barrier function in three-dimensional culture. PLoS One. 2011; 6 (8) : e22967. doi: 10.1371/journal.pone.0022967 PMID: 21853060
34. Elamin E, Masclee A, Troost F, Dekker J, Jonkers D. Activation of the Epithelial-To-Mesenchymal Transition Factor Snail Mediates Acetaldehyde-Induced Intestinal Epithelial Barrier Disruption. Alcohol Clin Exp Res. 2013 Aug 19.
35. Elamin E, Masclee A, Dekker J, Jonkers D. Ethanol disrupts intestinal epithelial tight junction integrity through intracellular calcium-mediated Rho/ROCK activation. Am J Physiol Gastrointest Liver Physiol. 2014 Apr; 306 (8) : G677-85. doi: 10.1152/ajpgi.00236.2013 PMID: 24557761
36. Wilcz-Villega EM, McClean S, O'Sullivan MA. Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome. Am J Gastroenterol. 2013 Jul; 108 (7) : 1140-51. doi: 10.1038/ajg.2013. 92 PMID: 23588236
37. Taira M, Tamaoki J, Kondo M, Kawatani K, Nagai A. Serum B12 tryptase level as a marker of allergic airway inflammation in asthma. J Asthma. 2002; 39 (4) : 315-22. PMID: 12095181
38. Hanson PJ, Moran AP, Butler K. Paracellular permeability is increased by basal lipopolysaccharide in a primary culture of colonic epithelial cells; an effect prevented by an activator of Toll-like receptor-2. Innate Immun. 2007.
39. Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol. 2013 Feb; 182 (2) : 375-87. doi: 10.1016/j.ajpath.2012.10.014 PMID: 23201091
40. Pastor Rojo O, Lopez San Roman A, Albeniz Arbizu E, de la Hera Martinez A, Ripoll Sevillano E, Albillos Martinez A. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007 Mar; 13 (3) : 269-77. PMID: 17206721
41. O'Dwyer ST, Michie HR, Ziegler TR, Revhaug A, Smith RJ, Wilmore DW. A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg. 1988 Dec; 123 (12) : 1459-64. PMID: 3142442
42. Keszthelyi D, Masclee AA. Effects of proton pump inhibitor therapy in the distal gut: putting the pieces together. Dig Dis Sci. 2012 Oct; 57 (10) : 2487-9. PMID: 22899240
43. Keszthelyi D, Dackus GH, Masclee GM, Kruimel JW, Masclee AA. Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study. BMC Gastroenterol. 2012; 12: 121. doi: 10.1186/1471-230X-12-121 PMID: 22950677
44. Ohmori T, Yang JL, Price JO, Arteaga CL. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy. Exp Cell Res. 1998 Dec 15; 245 (2) : 350-9. PMID: 9851876
45. Kim JB. Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol. 2005 Oct; 15-(5) : 365-77. PMID: 15975824